Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

SPRY ARS Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio of SPRY cannot be calculated, as the latest EPS of -$0.17 is negative. The most recent PE ratio recorded for ARS Pharmaceuticals was 131.88 in December 2024.

SPRY PE ratio history

How has SPRY's PE ratio performed in the past

Over the last four years, the average PE ratio of ARS Pharmaceuticals has been 39.15. Analyzing the last four years, SPRY's PE ratio reached its highest point in the Dec 2024 quarter at 131.88, with a price of $10.55 and an EPS of $0.08. The Sep 2021 quarter saw the lowest point at 0.61, with a price of $9.98 and an EPS of $16.31.

Today
N/A
Average
39.15
Median
9.96
Minimum
0.61
Maximum
131.88

ARS Pharmaceuticals PE ratio by year

Year PE ratio PE change Price EPS
2024 131.88 N/A $10.55 $0.08
2023 N/A N/A $5.48 -$0.57
2022 N/A N/A $8.53 -$0.87
2021 N/A N/A $6.66 -$0.7
2020 N/A N/A $46.34 -$11.33
2019 N/A N/A N/A -$36.27
2018 N/A N/A N/A -$29.11

ARS Pharmaceuticals PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $12.58 -$0.17
Dec 2024 131.88 N/A $10.55 $0.08
Sep 2024 N/A N/A $14.5 -$0.51
Jun 2024 N/A N/A $8.51 -$0.47
Mar 2024 N/A N/A $10.22 -$0.52
Dec 2023 N/A N/A $5.48 -$0.57
Sep 2023 N/A N/A $3.78 -$0.71
Jun 2023 N/A N/A $6.7 -$0.76
Mar 2023 N/A N/A $6.51 -$0.79
Dec 2022 N/A N/A $8.53 -$0.87
Sep 2022 9.96 -78.86% $5.28 $0.53
Jun 2022 47.11 N/A $4.24 $0.09
Mar 2022 N/A N/A $3.51 -$0.4
Dec 2021 N/A N/A $6.66 -$0.7
Sep 2021 0.61 -90.15% $9.98 $16.31

SPRY Price vs fair value

How does SPRY's price compare to its estimated fair value based on its growth

SPRY average PE ratio chart

What is the average PE ratio of SPRY for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

SPRY PE vs peers

What is SPRY's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $288.74M
OMER Omeros Corp N/A $195.7M
VIVS VivoSim Labs Inc. N/A $2.66M
ORIC Oric Pharmaceuticals Inc N/A $645.48M
ORMP Oramed Pharmaceuticals Inc N/A $93.14M
SPRY ARS Pharmaceuticals Inc N/A $1.36B

Frequently asked questions

What is ARS Pharmaceuticals's PE ratio?

The current price to earnings ratio of SPRY cannot be determined, as its EPS of -$0.17 is negative.

What is the highest PE ratio for SPRY?

Over the last four years, the Dec 2024 quarter recorded the highest quarterly PE ratio at 131.88.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.